Cerebras Asks Whether AI Scarcity Clears at 160 Dollars
Cerebras is asking public investors to buy AI scarcity at a higher price while OpenAI sits on both sides of the story.
The news. The narrative. The timeline.
Bureau: San Francisco
Cerebras is asking public investors to buy AI scarcity at a higher price while OpenAI sits on both sides of the story.
Apple's dividend calendar and capital-return filing give investors a concrete discipline story without needing succession tea leaves.
Apple has moved from announcing capital return to executing it as investors debate discipline versus defense.
A SpaceX prospectus would not arrive alone because Tesla has already put Musk-entity revenue on the page.
OpenAI's partner web is no longer only a slide deck because trial testimony has moved it into investor diligence.
Cloudflare's layoff lands differently because the company is not selling retreat, it is selling AI operating leverage.
Pfizer is telling investors to look at dividends, debt and drug launches before repurchases return.